Open AccessS700 Early Proactive IFX Dose Optimization Negates the Impact of HLA-DQA1*05 on Anti-Drug Antibody Formation in Inflammatory Bowel Diseases
Author(s) -
Elizabeth Spencer,
Jordan Stachelski,
Thierry Dervieux,
Marla Dubinsky
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776332.13982.cb
Subject(s) - medicine , infliximab , logistic regression , drug , cohort , pharmacology , tumor necrosis factor alpha